Rashmi K. Murthy
- Oncology top 1%
- HER2/EGFR in Cancer Research 41
- Cancer Treatment and Pharmacology 23
- Cancer Research top 5%
- Breast Cancer Treatment Studies 19
- Cancer Genomics and Diagnostics 9
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Advanced Breast Cancer Therapies 23
- Brain Metastases and Treatment 9
- Genetics top 5%
- BRCA gene mutations in cancer 8
- Co-authors
- Ian E. KropShanu ModiShunji TakahashiJunji TsurutaniCharles H. RedfernYasuaki SagaraCaleb LeeToshihiko Doi
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Rashmi K. Murthy
81 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 2.3k
- Cancer Research 599
- Radiology, Nuclear Medicine and Imaging 839
- Pulmonary and Respiratory Medicine 974
- Genetics 240
Countries citing papers authored by Rashmi K. Murthy
This map shows the geographic impact of Rashmi K. Murthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashmi K. Murthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashmi K. Murthy more than expected).
Fields of papers citing papers by Rashmi K. Murthy
This network shows the impact of papers produced by Rashmi K. Murthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashmi K. Murthy. The network helps show where Rashmi K. Murthy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rashmi K. Murthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 60 | |
| 7 | 2021 | 135 | |
| 8 | 2020 | 75 | |
| 9 | 2020 | 1 | |
| 10 | Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 studybreakdown → | 2019 | 258 |
| 11 | 2019 | 16 | |
| 12 | 2018 | 129 | |
| 13 | 2018 | 18 | |
| 14 | 2017 | 16 | |
| 15 | 2017 | 11 | |
| 16 | 2017 | 12 | |
| 17 | 2016 | 1 | |
| 18 | 2016 | 23 | |
| 19 | 2016 | 17 | |
| 20 | 2014 | 33 |
About Rashmi K. Murthy
Rashmi K. Murthy is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 85 papers that have together received 2.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (41 papers), Advanced Breast Cancer Therapies (23 papers), Cancer Treatment and Pharmacology (23 papers), Breast Cancer Treatment Studies (19 papers), Monoclonal and Polyclonal Antibodies Research (18 papers), Brain Metastases and Treatment (9 papers), Cancer Genomics and Diagnostics (9 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Oncology (2.3k citations), Cancer Research (599 citations) and Radiology, Nuclear Medicine and Imaging (839 citations). Rashmi K. Murthy has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ian E. Krop, Shanu Modi, Shunji Takahashi, Junji Tsurutani, Charles H. Redfern, Yasuaki Sagara, Caleb Lee, Toshihiko Doi, Hiroji Iwata and Javad Shahidi. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.